On Tuesday, May 27, an analyst from BTIG downgraded Globus Medical Inc. (NYSE:GMED) from Buy to Neutral, citing concerns ...

BTIG analysts have downgraded Globus Medical from "Buy" to "Neutral" amid fears surrounding the company's Spine business.

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $77.5, a high ...

Globus Medical (NYSE:GMED) announced that its board of directors authorized a share repurchase program totaling up to $500 million.

Medical device company Globus Medical (NYSE:GMED) will be announcing earnings results tomorrow after the bell. Here’s what to expect. Globus Medical beat analysts’ revenue expectations by 3.7% ...

The medical device market comprises companies that manufacture ... that Insider Monkey analyzed in the third quarter of 2022. Globus Medical, Inc. (NYSE:GMED) sells healthcare products and ...

Thornal will join the orthopedics company as group president for global businesses and the Americas, a newly created position ...

Globus Medical Inc is a leading innovator in the medical device industry, focusing on developing solutions for musculoskeletal disorders. With a broad portfolio, the company offers spine products ...

Feb 9 (Reuters) - Globus Medical Inc (GMED.N), opens new tab said on Thursday it would acquire peer NuVasive Inc (NUVA.O), opens new tab in an all-stock deal valued at about $3 billion to build ...

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into ...